Adviti Naik

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar.

Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar.

Journal: Frontiers in immunology

Published: December 07, 2025

Cell-Penetrating Peptide-Mediated siRNA Targeting of LDHC Suppresses Tumor Growth in a Triple-Negative Breast Cancer Zebrafish Xenograft Model.

Cell-Penetrating Peptide-Mediated siRNA Targeting of LDHC Suppresses Tumor Growth in a Triple-Negative Breast Cancer Zebrafish Xenograft Model.

Journal: Pharmaceutics

Published: December 05, 2025

Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.

Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.

Journal: Frontiers in immunology

Published: January 08, 2025

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer.

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer.

Journal: Cell communication and signaling : CCS

Published: September 24, 2024

Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.

Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.

Journal: Molecular therapy. Oncology

Published: April 10, 2024

The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival.

The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival.

Journal: Cancers

Published: December 07, 2023

Modulation of SLFN11 induces changes in DNA Damage response in breast cancer.

Modulation of SLFN11 induces changes in DNA Damage response in breast cancer.

Journal: Cancer cell international

Published: June 01, 2023

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer.

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer.

Journal: Frontiers in oncology

Published: December 04, 2022

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets.

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets.

Journal: Frontiers in oncology

Published: October 20, 2022

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.

Journal: Journal of translational medicine

Published: July 16, 2022

Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential.

Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential.

Journal: Journal of cellular and molecular medicine

Published: May 25, 2021

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort.

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort.

Journal: Viruses

Published: March 25, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026